Cargando…
Fibroblast Growth Factor 23 and Outcome Prediction in Patients with Acute Myocardial Infarction
(1) Background: Fibroblast growth factor 23 (FGF23) is associated with mortality in patients with heart failure (HF); however, less is known about mortality associations in patients with myocardial infarction (MI). (2) Methods: FGF23 was assessed in 180 patients with acute MI, 99 of whom presented w...
Autores principales: | Cornelissen, Anne, Florescu, Roberta, Kneizeh, Kinan, Cornelissen, Christian, Liehn, Elisa, Brandenburg, Vincent, Schuh, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837072/ https://www.ncbi.nlm.nih.gov/pubmed/35160052 http://dx.doi.org/10.3390/jcm11030601 |
Ejemplares similares
-
Intact fibroblast growth factor 23 levels and outcome prediction in patients with acute heart failure
por: Cornelissen, Anne, et al.
Publicado: (2021) -
The Role of Vitamin D(3) as an Independent Predicting Marker for One-Year Mortality in Patients with Acute Heart Failure
por: Thiele, Kirsten, et al.
Publicado: (2022) -
Dose-dependent impact of statin therapy intensity on circulating progenitor cells in patients undergoing percutaneous coronary intervention for the treatment of acute versus chronic coronary syndrome
por: Florescu, Roberta, et al.
Publicado: (2022) -
Phosphatidylserine Supplementation as a Novel Strategy for Reducing Myocardial Infarct Size and Preventing Adverse Left Ventricular Remodeling
por: Schumacher, David, et al.
Publicado: (2021) -
Biomechanical assessment of remote and postinfarction scar remodeling following myocardial infarction
por: Rusu, Mihaela, et al.
Publicado: (2019)